Maintaining intake of essential vitamins and minerals becomes even more critical during dietary changes
Reta: Appetite Regulation By stimulating GLP-1 and GIP receptors, Reta appears to signal satiety centers in the hypothalamus, potentially reducing food intake in preclinical animal models
A medical provider will review your history and help determine if injections are safe for you
Nausea is the most common, particularly during dose escalation
Reviewed by: Regentide Research Team | Last Updated: June 2026 Not all Retatrutide meets the same verification, consistency, batch-control, analytical documentation, and fulfillment standards
GLP3 , a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA